[Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress].
Pasqui
A L
AL
Cattedra e U.O. di Immunologia Clinica e Allergologia; Università degli Studi di Siena, Italia.
Bruni
F
F
Di Renzo
M
M
Saletti
M
M
Bova
G
G
Gotti
G
G
Auteri
A
A
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects*; D000917:Antibody Formation / Q000187:drug effects; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D007376:Interleukin-2 / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D016897:Respiratory Burst / Q000187:drug effects; D013312:Stress, Physiological / Q000209:etiology / Q000276:immunology*; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D053778:Thiazolidines
D000276:Adjuvants, Immunologic; D003176:Complement C3; D003181:Complement C4; D007376:Interleukin-2; D013844:Thiazoles; D053778:Thiazolidines; C064893:pidotimod; D011761:Pyrrolidonecarboxylic Acid